You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV- positive HNSCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • London, United Kingdom
    East and North Hertfordshire NHS Trust Mount Vernon Hospital
Aug 24, 2023

Head and Neck Squamous Cell Carcinoma Trial in New Haven (5-Azacitadine)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • New Haven, Connecticut
    Smilow Cancer Center at Yale New Haven Hospital
Feb 3, 2022

Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

Not yet recruiting
  • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
  • Monalizumab
  • Cetuximab
  • (no location specified)
Jan 8, 2023

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

Head Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma Trial in United States (CUE-101,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Tucson, Arizona
  • +16 more
Nov 15, 2022

Human Papillomavirus (HPV), Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in New York (radiation, other, drug)

Withdrawn
  • Human Papillomavirus (HPV)
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • RT 50 Gy
  • +6 more
  • New York, New York
    Mount Sinai Hospital
Jul 1, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Epigenetic Silencing of MicroRNA for Predicting Therapeutic

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Not interventional
    • Albuquerque, New Mexico
      University of New Mexico - Cancer Center
    Oct 4, 2022

    HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

    Not yet recruiting
    • HPV-Related Squamous Cell Carcinoma
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 31, 2023

    Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Combination 5-azacytidine and nivolumab
    • +2 more
    • (no location specified)
    Dec 7, 2022

    Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

    Recruiting
    • Solid Tumor
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    May 31, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Apr 20, 2022

    HSIL of Cervix Trial in Heze (NWRD08)

    Recruiting
    • HSIL of Cervix
    • NWRD08
    • Heze, Shandong, China
      Heze Municipal Hospital
    Jun 6, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Brescia, Italy
      Asst Degli Spedali Civili Di Brescia
    Aug 3, 2022

    Oral HPV Infection in Patients Who Are Positive to the PAP-test

    Recruiting
    • HPV Infection
      • Catania, Italy
        AOU Policlinico G. Rodolico
      Jul 13, 2023

      Oropharynx Squamous Cell Carcinoma Trial (Blood sample)

      Not yet recruiting
      • Oropharynx Squamous Cell Carcinoma
      • Blood sample
      • (no location specified)
      Jan 12, 2023

      Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

      Active, not recruiting
      • Squamous Cell Carcinoma of the Head and Neck
      • Squamous Cell Carcinoma, Head and Neck
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jun 21, 2022

      Women's Values in Managing Human Papillomavirus (HPV)

      Not yet recruiting
      • Human Papilloma Virus Infection
      • No intervention
      • (no location specified)
      Nov 6, 2023

      HNSCC Trial in Tucson (Abemaciclib)

      Recruiting
      • HNSCC
      • Tucson, Arizona
        University of Arizona
      Mar 3, 2022

      Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial

      Recruiting
      • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
      • +3 more
      • Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
      • L'Hospitalet De Llobregat, Catalunya, Spain
        Gynaecology Unit, Bellvitge University Hospital (HUB)
      Jan 24, 2023

      Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)

      Terminated
      • Head and Neck Squamous Cell Carcinoma
      • +2 more
      • RPTR-168
      • Scottsdale, Arizona
      • +3 more
      Dec 2, 2022

      Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

      Recruiting
      • Head and Neck Carcinoma
      • Adult Disease
      • HPVDC injection level dose 1
      • +3 more
      • Villejuif, France
        Gustave Roussy
      Aug 17, 2023

      HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Boston (Blood test for HPV DNA)

      Recruiting
      • HPV Positive Oropharyngeal Squamous Cell Carcinoma
      • Blood test for HPV DNA
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jun 8, 2022